A Shifting Procedural Landscape: Q322 Spine Market Recap

SmartTRAK reports that Q322 Spine Market performance drove a lack of consensus on operational performance metrics, while a shifting procedural landscape offered new product opportunities for small and mid-tier players, driving competitive pressure.

Among the many topics covered in detail in our comprehensive Q322 Spine Market Recap* are:

• Complete Q322 Spine Market Overview and Highlights
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• Top Player Performance
• Lack of Consensus for Three Key Operational Performance Indicators
• Competitive Pressure Continues to Pose Opportunity for Smaller Players to Gain Share
• Q322 Spine Market Regulatory Highlights

With the procedural landscape shifting post COVID-19 and offering the opportunity to introduce new products to providers and clinicians by way of ASCs and other avenues, some of the key spine players are feeling the heat of competition and creating strategies to respond. JNJ* management stated that Q322 momentum gained from new product introductions was offset by competition and Stryker* noted that ...

Read the entire Q322 Spine Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.